In one such example, the widely used Huntington’s Disease (HD) mice model HttQ111 was subjected to CRISPR KO of probable candidate genes that could modify the number of CAG repeats in Htt, which is directly correlated with HD severity. This evidence concerns the gene HTT and Huntington disease.